These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6765523)
1. A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients. Clark AJ; Wiles PG; Leiper JM; Knight G; Adeniyl-Jones RO; Watkins PJ; Ward JD; MacCuish AC; Keen H; Jones RH Diabetes Care; 1982; 5 Suppl 2():129-34. PubMed ID: 6765523 [TBL] [Abstract][Full Text] [Related]
2. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study. Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526 [TBL] [Abstract][Full Text] [Related]
3. Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients. Clark AJ; Adeniyi-Jones RO; Knight G; Leiper JM; Wiles PG; Jones RH; Keen H; MacCuish AC; Ward JD; Watkins PJ; Cauldwell JM; Glynne A; Scotton JB Lancet; 1982 Aug; 2(8294):354-7. PubMed ID: 6124760 [TBL] [Abstract][Full Text] [Related]
4. Need stable diabetics mix their insulins? Roland JM Diabet Med; 1984 May; 1(1):51-3. PubMed ID: 6242778 [TBL] [Abstract][Full Text] [Related]
5. Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA). Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ Diabetes Care; 1982; 5 Suppl 2():107-13. PubMed ID: 6765519 [TBL] [Abstract][Full Text] [Related]
6. Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens. Davies RR; McEwen J; Moreland TA; Durnin C; Newton RW Diabet Med; 1988 Oct; 5(7):671-5. PubMed ID: 2975553 [TBL] [Abstract][Full Text] [Related]
7. Crossover study with human insulin (recombinant DNA) in type I diabetic subjects. Landgraf R; Kammerer S; Bock T; Smolka B; Ladik T; Enzmann F; Landgraf-Leurs MM Diabetes Care; 1982; 5 Suppl 2():39-42. PubMed ID: 6765538 [TBL] [Abstract][Full Text] [Related]
8. A fifteen-month double-blind cross-over study of the efficacy and antigenicity of human and pork insulins. Home PD; Mann NP; Hutchison AS; Park R; Walford S; Murphy M; Reeves WG Diabet Med; 1984 Jul; 1(2):93-8. PubMed ID: 6086002 [TBL] [Abstract][Full Text] [Related]
9. The U.S. "new patient" and "transfer" studies. Galloway JA; Peck FB; Fineberg SE; Spradlin CT; Marsden JH; Allemenos D; Ingulli-Fattic J Diabetes Care; 1982; 5 Suppl 2():135-9. PubMed ID: 6765525 [TBL] [Abstract][Full Text] [Related]
10. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. Rosenstock J; Park G; Zimmerman J; Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511 [TBL] [Abstract][Full Text] [Related]
11. A comparison of semisynthetic human NPH insulin and porcine NPH insulin in the treatment of insulin-dependent diabetes mellitus. Pedersen C; Høegholm A Diabet Med; 1987; 4(4):304-6. PubMed ID: 2956040 [TBL] [Abstract][Full Text] [Related]
12. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study. Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of NPH human insulin (recombinant DNA) and pork insulin in diabetic subjects: preliminary report. Mirouze J; Monnier L; Richard JL; Gancel A; Soua KB Diabetes Care; 1982; 5 Suppl 2():60-2. PubMed ID: 6765543 [TBL] [Abstract][Full Text] [Related]
14. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro. Ahmed AB; Mallias J; Home PD Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613 [TBL] [Abstract][Full Text] [Related]
15. Human (recombinant DNA) and porcine NPH insulins are unequally effective in diabetic patients. A comparative study using continuous blood glucose monitoring. Richard JL; Rodier M; Cavalié G; Mirouze J; Monnier L Acta Diabetol Lat; 1984; 21(3):211-7. PubMed ID: 6393670 [TBL] [Abstract][Full Text] [Related]
16. Immunological and metabolic responses of patients with history of antibody-induced beef insulin resistance to treatment with beef, pork, human, and sulfated beef insulin. Davidson JK; Fineberg SE; De Meyts P; Fineberg NS; Galloway JA Diabetes Care; 1992 May; 15(5):702-4. PubMed ID: 1516491 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals. Sailer D; Ludwig T; Kolb S Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542 [TBL] [Abstract][Full Text] [Related]
18. Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulin. Parillo M; Mura A; Iovine C; Rivellese AA; Lavicoli M; Riccardi G Diabetes Care; 1992 Feb; 15(2):173-7. PubMed ID: 1547673 [TBL] [Abstract][Full Text] [Related]
19. Human ultralente insulin. Holman RR; Steemson J; Darling P; Reeves WG; Turner RC Br Med J (Clin Res Ed); 1984 Mar; 288(6418):665-8. PubMed ID: 6421424 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of NPH human insulin (recombinant DNA) and NPH bovine insulin in diabetic subjects. Marre M; Tabbi-Anneni A; Tabbi-Anneni H; Assan R Diabetes Care; 1982; 5 Suppl 2():63-6. PubMed ID: 6765544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]